Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation
Ted A. Gooley, Pankaj Rajvanshi, H. Gary Schoch, George B. McDonald – 19 January 2005 – Many patients who undergo hematopoietic cell transplantation experience liver injury. We examined the association of serum bilirubin levels with nonrelapse mortality by day +200, testing the hypothesis that the duration of jaundice up to a given point in time provides more prognostic information than either the maximum bilirubin value or the value at that point in time. We studied 1,419 consecutive patients transplanted from allogeneic donors.